WolfeRR. Review: acute versus chronic response to burn injury. Circ Shock. 1981;8:105-115.
3.
JeschkeMGChinkesDLFinnertyCC, et al. Pathophysiologic response to severe burn injury. Ann Surg. 2008;248:387-401. doi:10.1097/SLA.0b013e3181856241
4.
HerndonDNTompkinsRG. Support of the metabolic response to burn injury. Lancet. 2004;363:1895-1902. doi:10.1016/S0140-6736(04)16360-5
5.
JeschkeMG. Postburn hypermetabolism: past, present, and future. J Burn Care Res. 2016;37:86-96. doi:10.1097/BCR.0000000000000265
6.
WilliamsFNJeschkeMGChinkesDLSumanOEBranskiLKHerndonDN. Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg. 2009;208:489-502. doi:10.1016/j.jamcollsurg.2009.01.022
7.
HerndonDNRodriguezNADiazEC, et al. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Ann Surg. 2012;256:402-411. doi:10.1097/SLA.0b013e318265427e
8.
KulpGAHerndonDNLeeJOSumanOEJeschkeMG. Extent and magnitude of catecholamine surge in pediatric burned patients. Shock. 2010;33:369-374. doi:10.1097/SHK.0b013e3181b92340
9.
GauglitzGGHerndonDNKulpGAMeyerWJJeschkeMG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab. 2009;94:1656-1664. doi:10.1210/jc.2008-1947
10.
HartDWWolfSEMlcakR, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000;128:312-319. doi:10.1067/msy.2000.108059
HerndonDNHartDWWolfSEChinkesDLWolfeRR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223-1229. doi:10.1056/NEJMoa010342
13.
WilliamsFNHerndonDNSumanOE, et al. Changes in cardiac physiology after severe burn injury. J Burn Care Res. 2011;32:269-274. doi:10.1097/BCR.0b013e31820aafcf
14.
OberbeckRSchmitzDWilsenackK, et al. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation. 2004;11:214-223. doi:10.1159/000078439
15.
JeschkeMGNorburyWBFinnertyCCBranskiLKHerndonDN. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma. 2007;62:676-681. doi:10.1097/TA.0b013e318031afd3
SuzukiTSuzukiYOkudaJ, et al. Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. J Intensive Care. 2017;5:22. doi:10.1186/s40560-017-0215-2
20.
SchmittingerCADünserMWHallerM, et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care. 2008;12:R99. doi:10.1186/cc6976
21.
MorelliAErtmerCWestphalM, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683-1691. doi:10.1001/jama.2013.278477
22.
GoreDCWolfeRR. Hemodynamic and metabolic effects of selective β1 adrenergic blockade during sepsis. Surgery. 2006;139:686-694. doi:10.1016/j.surg.2005.10.010